Fiddes T M, O'Reilly D B, Cetrulo C L, Miller W, Rudders R, Osband M, Rocklin R E
Cell Immunol. 1986 Feb;97(2):407-18. doi: 10.1016/0008-8749(86)90410-7.
To evaluate the potential role of immunoregulatory cells modulating the maternal immunologic response during pregnancy, we carried out phenotypic and functional studies in patients with normal obstetrical histories during each trimester and in patients with chronic idiopathic spontaneous abortions. Using monoclonal antibodies (Ortho), total numbers of T cells (T3+) and T4+ cells progressively increased during pregnancy (compared to nonpregnant controls) and then declined in the third trimester. Increased percentages of T8+, T10+, and Ia+ cells were found in the third trimester. The relative decline in numbers of T4+ cells, with increased numbers of T8+ cells, led to a significantly reduced T4/T8 ratio in the third trimester. Histamine receptors on T cells were quantitated by an immunofluorescent technique. Significantly reduced numbers of H1-type receptors were noted during the second trimester of pregnancy and this was associated with a decreased H1/H2 ratio. Functionally, histamine-induced suppression was measured in a lymphocyte proliferation assay. Patients in the first and second trimester of pregnancy had greater histamine-induced suppression of phytohemagglutinin (PHA)-stimulated proliferation at high concentrations of histamine (10(-3) to 10(-7)) but less suppression at the lower concentrations (10(-9) to 10(-11) M), compared to nonpregnant controls. In contrast, patients studied in the third trimester failed to respond to any concentration of histamine. MLC-induced suppressor activity was generated by incubating the maternal cells with either paternal or third-party mononuclear cells for 2 or 6 days and assaying the cell-free supernatant for its suppressive effects on PHA-stimulated proliferation. Maternal responses to paternal cells did not result in significant suppression in 2-day supernatants during any trimester but by 6 days the suppressive activity was equivalent to non-pregnant controls in patients during the first and second trimester. Maternal responses to third party cells was greater during the second trimester than either the first or third trimesters in both 2- and 6-day supernatants. Patients with histories of chronic idiopathic spontaneous abortions, who were not pregnant at the time of study, exhibited normal numbers of T-cell subsets and T4/T8 ratios. Numbers of both H1 and H2 receptor bearing T cells were proportionally reduced, resulting in a normal H1/H2 ratio. Despite having decreased numbers of H1 and H2 receptor bearing cells, histamine-induced suppression of PHA-stimulated proliferation was comparable to nonpregnant controls over the concentration range (10(-3) to 10(-11) M) employed.(ABSTRACT TRUNCATED AT 400 WORDS)
为评估免疫调节细胞在孕期调节母体免疫反应中的潜在作用,我们对各孕期有正常产科病史的患者以及慢性特发性自然流产患者进行了表型和功能研究。使用单克隆抗体(Ortho公司产品),T细胞(T3 +)和T4 +细胞总数在孕期逐渐增加(与未孕对照组相比),然后在孕晚期下降。孕晚期T8 +、T10 +和Ia +细胞百分比增加。T4 +细胞数量相对减少,T8 +细胞数量增加,导致孕晚期T4/T8比值显著降低。通过免疫荧光技术对T细胞上的组胺受体进行定量。在妊娠中期观察到H1型受体数量显著减少,这与H1/H2比值降低有关。在功能方面,通过淋巴细胞增殖试验测定组胺诱导的抑制作用。与未孕对照组相比,妊娠早期和中期的患者在高浓度组胺(10(-3)至10(-7))时,组胺对植物血凝素(PHA)刺激的增殖具有更强的抑制作用,但在较低浓度(10(-9)至10(-11) M)时抑制作用较小。相比之下,孕晚期研究的患者对任何浓度的组胺均无反应。混合淋巴细胞培养诱导的抑制活性是通过将母体细胞与父方或第三方单核细胞孵育2天或6天,然后检测无细胞上清液对PHA刺激的增殖的抑制作用来产生的。在任何孕期,母体对父方细胞的反应在2天的上清液中均未导致显著抑制,但到6天时,妊娠早期和中期患者的抑制活性与未孕对照组相当。在2天和6天的上清液中,妊娠中期母体对第三方细胞的反应均大于妊娠早期或晚期。研究时未怀孕的慢性特发性自然流产病史患者表现出正常数量的T细胞亚群和T4/T8比值。携带H1和H2受体的T细胞数量均成比例减少,导致H1/H2比值正常。尽管携带H1和H2受体的细胞数量减少,但在所采用的浓度范围(10(-3)至10(-11) M)内,组胺对PHA刺激的增殖的抑制作用与未孕对照组相当。(摘要截于400字)